SAFETY PROFILE OF VACCINES AGAINST SARS-COV-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM PROSPECTIVE MULTICENTRIC STUDY - SAFER STUDY

Authors
Category Primary study
JournalJ. Rheumatol.
Year 2025
This article has no abstract
Epistemonikos ID: 0f6a05c7dc007803b3faa753f8d3601b3ad71005
First added on: Jul 08, 2025